Dimensional Fund Advisors LP Has $8.67 Million Stake in OrthoPediatrics Corp. $KIDS

Key Points

• Dimensional Fund Advisors reduced its OrthoPediatrics stake by 12.2% in the first quarter, selling 75,793 shares but retaining 546,626 shares worth approximately $8.67 million. Institutional investors and hedge funds collectively own 69.05% of KIDS.
• Analysts remain broadly positive, with nine Buy ratings, one Hold and one Sell. The stock has a “Moderate Buy” consensus rating and a $25.89 average price target, including Piper Sandler’s increased $25 target.
• OrthoPediatrics beat quarterly expectations, reporting a loss of $0.26 per share versus the projected $0.30 loss and revenue of $70.51 million versus the $68.21 million estimate. Shares opened at $22.77, near their 12-month high of $23.17.

Dimensional Fund Advisors LP lowered its stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 12.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 546,626 shares of the company's stock after selling 75,793 shares during the period. Dimensional Fund Advisors LP owned approximately 2.13% of OrthoPediatrics worth $8,674,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the stock. Millennium Management LLC raised its position in shares of OrthoPediatrics by 48.0% in the 4th quarter. Millennium Management LLC now owns 1,396,495 shares of the company's stock valued at $24,802,000 after acquiring an additional 452,840 shares during the period. Vanguard Group Inc. boosted its stake in OrthoPediatrics by 1.1% during the 3rd quarter. Vanguard Group Inc. now owns 961,330 shares of the company's stock worth $17,813,000 after acquiring an additional 10,927 shares during the last quarter. Marshall Wace LLP grew its holdings in OrthoPediatrics by 6.0% during the third quarter. Marshall Wace LLP now owns 444,320 shares of the company's stock valued at $8,233,000 after purchasing an additional 25,191 shares during the period. Wasatch Advisors LP grew its holdings in OrthoPediatrics by 13.6% during the first quarter. Wasatch Advisors LP now owns 329,320 shares of the company's stock valued at $5,226,000 after purchasing an additional 39,451 shares during the period. Finally, Roubaix Capital LLC increased its stake in OrthoPediatrics by 23.8% in the first quarter. Roubaix Capital LLC now owns 290,047 shares of the company's stock valued at $4,603,000 after purchasing an additional 55,724 shares in the last quarter. 69.05% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

KIDS has been the topic of several analyst reports. Piper Sandler reiterated an "overweight" rating and issued a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a report on Wednesday. Truist Financial set a $22.00 price target on shares of OrthoPediatrics in a report on Wednesday. TD Cowen restated a "buy" rating on shares of OrthoPediatrics in a research report on Monday, June 15th. BTIG Research reaffirmed a "buy" rating and set a $24.00 price objective on shares of OrthoPediatrics in a research note on Friday, May 1st. Finally, Canaccord Genuity Group set a $25.00 price objective on OrthoPediatrics in a research note on Friday, April 24th. Nine research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, OrthoPediatrics currently has an average rating of "Moderate Buy" and a consensus price target of $25.89.

OrthoPediatrics Price Performance

OrthoPediatrics stock opened at $22.77 on Monday. The company has a 50 day moving average of $19.39 and a 200-day moving average of $17.91. The company has a quick ratio of 2.17, a current ratio of 4.78 and a debt-to-equity ratio of 0.28. OrthoPediatrics Corp. has a twelve month low of $14.42 and a twelve month high of $23.17. The stock has a market capitalization of $594.52 million, a PE ratio of -13.55 and a beta of 0.98.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) EPS for the quarter, topping analysts' consensus estimates of ($0.30) by $0.04. The business had revenue of $70.51 million for the quarter, compared to analyst estimates of $68.21 million. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. On average, equities research analysts anticipate that OrthoPediatrics Corp. will post -1.14 EPS for the current fiscal year.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company's product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source